{
    "Trade/Device Name(s)": [
        "ACTIVE\u00ae Free Testosterone RIA"
    ],
    "Submitter Information": "IMMUNOTECH s.r.o.",
    "510(k) Number": "K191350",
    "Predicate Device Reference 510(k) Number(s)": [
        "K952281"
    ],
    "Regulatory Class": "Class I, reserved",
    "Product Code(s)": [
        "CDZ"
    ],
    "Summary Letter Date": "November 25, 2019",
    "Summary Letter Received Date": "November 25, 2019",
    "Submission Date": "October 19, 2019",
    "Regulation Number(s)": [
        "21 CFR 862.1680"
    ],
    "Regulation Name(s)": [
        "Testosterone Test System"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Free testosterone"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "Plastic tubes with rabbit anti-testosterone immunoglobulin",
        "Standard blood collection tube for serum"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Radioimmunoassay (RIA)",
        "Competitive binding assay",
        "125I-labeled testosterone analog tracer"
    ],
    "Methodologies": [
        "Radioimmunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for IMMUNOTECH ACTIVE\u00ae Free Testosterone RIA radioimmunoassay for quantitative measurement of free testosterone in human serum.",
    "Indications for Use Summary": "Radioimmunoassay for the quantitative measurement of free testosterone in human serum, intended for in vitro diagnostic use in the diagnosis and treatment of disorders involving androgens in males and females.",
    "fda_folder": "Clinical Chemistry"
}